HPV (Human Papillomavirus): Also Called the Human Wart Virus
HPV is a group of >200 related viruses. **~40 types infect the genital tract.** They are categorized by cancer risk:
Low-Risk (Non-Oncogenic)
- HPV 6, 11 → **90% of genital warts** (condylomata acuminata).
- Also cause recurrent respiratory papillomatosis (RRP).
High-Risk (Oncogenic)
- HPV 16, 18 → **70% of cervical cancers**; major cause of oropharyngeal, anal, vulvar, vaginal, penile cancers.
- Others: 31, 33, 45, 52, 58, etc.
Transmission & Natural History
- Skin-to-skin sexual contact (penetration not required).
- **Most infections clear spontaneously** in 1-2 years (cell-mediated immunity).
- Persistent high-risk infection → precancer → cancer (10-30 years).
Prevention
- HPV vaccine (Gardasil 9): Covers 6, 11, 16, 18, 31, 33, 45, 52, 58. **Recommended 11-12 yrs (9-26 routine); shared decision-making 27-45.**
- Condoms reduce but don't eliminate risk (uncovered skin).
- Cervical screening: Pap + HPV co-testing (30-65) or primary HPV (25-65).
Treatment
- Warts: Topical (imiquimod, podofilox, sinecatechins), ablative (cryo, TCA, laser, excision).
- Precancer (CIN): Excision (LEEP, cold knife cone), ablation.
- Cancer: Surgery, radiation, chemo, immunotherapy.
HPV is ubiquitous; vaccination + screening prevent virtually all cervical cancer.
Human Papillomavirus (HPV) - Related Articles
- HPV Subtypes: High-Risk vs. Low-Risk Types and Associated Health Conditions
- Hi-C & Chromosome Conformation Capture: Techniques for 3D Genome Architecture
- Understanding HPV: History, Types, and Cancer Risks
- Understanding HPV: Prevention, Symptoms & Treatment
- Understanding Potassium Chloride in Normal Saline (KCl 0.9%)
- Human Papillomavirus (HPV): Origins, History & Risks
- COVID-19 Recovery: Timeline, Long COVID Symptoms, and Healing Strategies
